HK1248762A1 - 高功能性血小板的製造方法 - Google Patents
高功能性血小板的製造方法Info
- Publication number
- HK1248762A1 HK1248762A1 HK18108449.0A HK18108449A HK1248762A1 HK 1248762 A1 HK1248762 A1 HK 1248762A1 HK 18108449 A HK18108449 A HK 18108449A HK 1248762 A1 HK1248762 A1 HK 1248762A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- performance
- platelet manufacturing
- platelet
- manufacturing
- performance platelet
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0644—Platelets; Megakaryocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/19—Platelets; Megacaryocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0669—Bone marrow stromal cells; Whole bone marrow
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/60—Transcription factors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/65—MicroRNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/70—Enzymes
- C12N2501/72—Transferases (EC 2.)
- C12N2501/727—Kinases (EC 2.7.)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Rheumatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2015121456 | 2015-06-16 | ||
PCT/JP2016/068015 WO2016204256A1 (ja) | 2015-06-16 | 2016-06-16 | 高機能性血小板の製造方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1248762A1 true HK1248762A1 (zh) | 2018-10-19 |
Family
ID=57545938
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK18108449.0A HK1248762A1 (zh) | 2015-06-16 | 2018-06-29 | 高功能性血小板的製造方法 |
Country Status (13)
Country | Link |
---|---|
US (1) | US10947504B2 (zh) |
EP (1) | EP3312270B1 (zh) |
JP (1) | JP6814507B2 (zh) |
KR (1) | KR102600772B1 (zh) |
CN (1) | CN107709546B (zh) |
AU (1) | AU2016278335B2 (zh) |
CA (1) | CA2989755A1 (zh) |
DK (1) | DK3312270T3 (zh) |
ES (1) | ES2839220T3 (zh) |
HK (1) | HK1248762A1 (zh) |
RU (1) | RU2724533C2 (zh) |
SG (1) | SG11201710342TA (zh) |
WO (1) | WO2016204256A1 (zh) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017011550A1 (en) | 2015-07-13 | 2017-01-19 | University Of Utah Research Foundation | Methods of making red blood cells and platelets in vitro and uses thereof |
SG11201802159UA (en) * | 2015-10-14 | 2018-04-27 | Megakaryon Corp | Method for producing purified platelets |
US11952587B2 (en) | 2017-03-06 | 2024-04-09 | Kyoto University | Method for producing platelets |
JP7002720B2 (ja) * | 2017-07-28 | 2022-01-20 | 国立大学法人京都大学 | AhRアンタゴニストを含む血小板産生促進剤及びそれを用いた血小板の製造方法 |
CA3073956A1 (en) | 2017-09-03 | 2019-03-07 | Angion Biomedica Corp. | Vinylheterocycles as rho-associated coiled-coil kinase (rock) inhibitors |
CN112654627A (zh) | 2018-09-07 | 2021-04-13 | 大塚制药株式会社 | 杂环化合物 |
JPWO2020184685A1 (zh) * | 2019-03-13 | 2020-09-17 | ||
WO2021067378A1 (en) * | 2019-10-01 | 2021-04-08 | University Of Utah Research Foundation | Methods of engineering platelets for targeting circulating tumor cells |
WO2021117733A1 (en) * | 2019-12-09 | 2021-06-17 | Otsuka Pharmaceutical Co., Ltd. | Acrylamide compounds |
EP4074321A4 (en) | 2019-12-12 | 2024-01-03 | Univ Chiba Nat Univ Corp | FREEZE DRIED PREPARATION CONTAINING MEGAKARYOCYTES AND PLATELETS |
JP2021180620A (ja) | 2020-05-18 | 2021-11-25 | 株式会社マイオリッジ | 目的細胞の生産方法、目的細胞による生産物の生産方法、および無血清培地 |
WO2024085650A1 (ko) * | 2022-10-18 | 2024-04-25 | 의료법인 성광의료재단 | 줄기세포에서 혈소판 전구세포로의 분화 유도용 배지 조성물 및 이를 이용한 분화 방법 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT1542714E (pt) * | 2002-09-18 | 2014-06-23 | Janssen Pharmaceuticals Inc | Métodos para aumentar a produção de células estaminais plaquetárias e hematopoiéticas |
US8933071B2 (en) * | 2008-11-07 | 2015-01-13 | Northwestern University | Dimethyl fasudil for inducing polyploidization of megakaryocytes and for treating blood and bone marrow diseases and disorders |
PL2352815T3 (pl) * | 2008-12-04 | 2016-07-29 | Inst Nat Sante Rech Med | Sposób wytwarzania płytek krwi |
US9574178B2 (en) | 2011-03-18 | 2017-02-21 | New York Blood Center, Inc. | Megakaryocyte and platelet production from stem cells |
US9803164B2 (en) * | 2011-03-18 | 2017-10-31 | New York Blood Center, Inc. | Megakaryocyte and platelet production from stem cells |
DK2708597T3 (en) | 2011-05-13 | 2018-02-05 | Univ Tokyo | POLYNUCLEAR MEGACARYOCYTIC CELL AND METHOD FOR PRODUCING BLADETS |
US9074186B2 (en) * | 2012-08-15 | 2015-07-07 | Boston Medical Center Corporation | Production of red blood cells and platelets from stem cells |
ES2896354T3 (es) * | 2012-12-21 | 2022-02-24 | Astellas Inst For Regenerative Medicine | Métodos para la producción de plaquetas a partir de células madre pluripotentes |
WO2014138485A1 (en) * | 2013-03-08 | 2014-09-12 | Irm Llc | Ex vivo production of platelets from hematopoietic stem cells and the product thereof |
EP2970881A4 (en) * | 2013-03-14 | 2017-01-25 | Children's Medical Center Corporation | Compositions and methods for reprogramming hematopoietic stem cell lineages |
-
2016
- 2016-06-16 ES ES16811730T patent/ES2839220T3/es active Active
- 2016-06-16 US US15/735,685 patent/US10947504B2/en active Active
- 2016-06-16 DK DK16811730.7T patent/DK3312270T3/da active
- 2016-06-16 EP EP16811730.7A patent/EP3312270B1/en active Active
- 2016-06-16 KR KR1020187001008A patent/KR102600772B1/ko active IP Right Grant
- 2016-06-16 SG SG11201710342TA patent/SG11201710342TA/en unknown
- 2016-06-16 AU AU2016278335A patent/AU2016278335B2/en active Active
- 2016-06-16 JP JP2017524841A patent/JP6814507B2/ja active Active
- 2016-06-16 CN CN201680035205.0A patent/CN107709546B/zh active Active
- 2016-06-16 CA CA2989755A patent/CA2989755A1/en not_active Abandoned
- 2016-06-16 WO PCT/JP2016/068015 patent/WO2016204256A1/ja active Application Filing
- 2016-06-16 RU RU2018101211A patent/RU2724533C2/ru active
-
2018
- 2018-06-29 HK HK18108449.0A patent/HK1248762A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
CN107709546B (zh) | 2022-04-22 |
RU2018101211A (ru) | 2019-07-16 |
JP6814507B2 (ja) | 2021-01-20 |
KR20180017154A (ko) | 2018-02-20 |
EP3312270A4 (en) | 2018-12-12 |
KR102600772B1 (ko) | 2023-11-13 |
RU2724533C2 (ru) | 2020-06-23 |
WO2016204256A1 (ja) | 2016-12-22 |
EP3312270B1 (en) | 2020-09-30 |
CA2989755A1 (en) | 2016-12-22 |
AU2016278335A1 (en) | 2018-01-18 |
EP3312270A1 (en) | 2018-04-25 |
ES2839220T3 (es) | 2021-07-05 |
AU2016278335B2 (en) | 2021-10-28 |
DK3312270T3 (da) | 2020-10-12 |
RU2018101211A3 (zh) | 2019-11-27 |
US10947504B2 (en) | 2021-03-16 |
JPWO2016204256A1 (ja) | 2018-05-31 |
CN107709546A (zh) | 2018-02-16 |
US20190048317A1 (en) | 2019-02-14 |
SG11201710342TA (en) | 2018-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1248762A1 (zh) | 高功能性血小板的製造方法 | |
GB201609027D0 (en) | Waveguide manufacturing method | |
GB201609026D0 (en) | Waveguide manufacturing method | |
GB201614505D0 (en) | Additive manufacturing | |
GB201514977D0 (en) | Additive layer manufacturing | |
SG11201507206TA (en) | Formed material manufacturing method | |
GB201508289D0 (en) | Additive manufacturing | |
GB201614503D0 (en) | Additive manufacturing | |
EP3397399A4 (en) | METHOD FOR CONTINUOUS GENERATIVE MANUFACTURING | |
GB201416223D0 (en) | Manufacturing method | |
GB201604662D0 (en) | Additive manufacturing | |
GB2548672B (en) | Additive manufacturing method | |
GB2542906B (en) | Particulates for Additive Manufacturing Techniques | |
EP3265120C0 (en) | PROCEDURE | |
SG11201705232YA (en) | Resonator manufacturing method | |
GB201409650D0 (en) | Manufacturing methods | |
EP3386618A4 (en) | ULTRAVARIABLE ADVANCED MANUFACTURING TECHNIQUES | |
SI3317889T1 (sl) | Proizvodnja magneta | |
SG11201707437RA (en) | Formed material manufacturing method | |
GB201509033D0 (en) | Additive layer manufacturing method | |
GB201502244D0 (en) | Method for manufacturing graphene platelets | |
HK1254798A1 (zh) | 用於製造1-環丙基萘的方法 | |
GB201518266D0 (en) | Method for manufacturing continuous wire | |
EP3222760A4 (en) | Acrylic-fiber manufacturing method | |
GB201718144D0 (en) | Manufacturing method |